About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 385604, 8 pages
http://dx.doi.org/10.1155/2013/385604
Research Article

CD133 Expression in Normal Skin and in Epithelial Cutaneous Tumors

1Department of Pathology, University General Hospital, 03003 Albacete, Spain
2AECC Translational Oncologic Research Unit, University General Hospital, 03003 Albacete, Spain
3Department of Dermatology, University General Hospital, 03003 Albacete, Spain
4Regulation of Cell Growth Laboratory, Inbiomed Foundation, 20009 San Sebastian, Spain
5Department of Pathology, University General Hospital and Murcia University, 30003 Murcia, Spain

Received 30 April 2013; Revised 14 July 2013; Accepted 24 July 2013

Academic Editor: Francesco Del Galdo

Copyright © 2013 S. H. Nam-Cha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Sellheyer, “Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers,” British Journal of Dermatology, vol. 164, no. 4, pp. 696–711, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Sellheyer, P. Nelson, and D. Krahl, “Dermatofibrosarcoma protuberans: a tumour of nestin-positive cutaneous mesenchymal stem cells?” British Journal of Dermatology, vol. 161, no. 6, pp. 1317–1322, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Bauer, A.-V. Fonseca, M. Florek et al., “New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133),” Cells Tissues Organs, vol. 188, no. 1-2, pp. 127–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Miraglia, W. Godfrey, A. H. Yin et al., “A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning,” Blood, vol. 90, no. 12, pp. 5013–5021, 1997. View at Scopus
  5. A. H. Yin, S. Miraglia, E. D. Zanjani et al., “AC133, a novel marker for human hematopoietic stem and progenitor cells,” Blood, vol. 90, no. 12, pp. 5002–5012, 1997. View at Scopus
  6. C. Sagrinati, G. S. Netti, B. Mazzinghi et al., “Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys,” Journal of the American Society of Nephrology, vol. 17, no. 9, pp. 2443–2456, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. D. Richardson, C. N. Robson, S. H. Lang, D. E. Neal, N. J. Maitland, and A. T. Collins, “CD133, a novel marker for human prostatic epithelial stem cells,” Journal of Cell Science, vol. 117, no. 16, pp. 3539–3545, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Weigmann, D. Corbeil, A. Hellwig, and W. B. Huttner, “Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 23, pp. 12425–12430, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Immervoll, D. Hoem, P. Sakariassen, O. J. Steffensen, and A. Molven, “Expression of the “stem cell marker” CD133 in pancreas and pancreatic ductal adenocarcinomas,” BMC Cancer, vol. 8, article 48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Wang, Z. Y. Xu, L. F. Wang, and W. Su, “CD133+ cancer stem cells in lung cancer,” Frontiers in Bioscience, vol. 18, pp. 447–453, 2013. View at Publisher · View at Google Scholar
  11. M. Florek, M. Haase, A.-M. Marzesco et al., “Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer,” Cell and Tissue Research, vol. 319, no. 1, pp. 15–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. W. M. Klein, B. P. Wu, S. Zhao, H. Wu, A. J. P. Klein-Szanto, and S. R. Tahan, “Increased expression of stem cell markers in malignant melanoma,” Modern Pathology, vol. 20, no. 1, pp. 102–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Suetsugu, M. Nagaki, H. Aoki, T. Motohashi, T. Kunisada, and H. Moriwaki, “Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells,” Biochemical and Biophysical Research Communications, vol. 351, no. 4, pp. 820–824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Karbanová, E. Missol-Kolka, A.-V. Fonseca et al., “The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia,” Journal of Histochemistry and Cytochemistry, vol. 56, no. 11, pp. 977–993, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Mizrak, M. Brittan, and M. R. Alison, “CD133: molecule of the moment,” Journal of Pathology, vol. 214, no. 1, pp. 3–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. E. LeBoit, D. Weedon, and A. Sarasin, Eds., Pathology and Genetics of Skin Tumours, World Heatlh Organization, Lyon, France, 2005.
  17. S. Chen, M. Takahara, M. Kido et al., “Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma,” British Journal of Dermatology, vol. 159, no. 4, pp. 952–955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Bieniek, A. J. F. Lazar, C. Photopoulos, and S. Lyle, “Sebaceous tumours contain a subpopulation of cells expressing the keratin 15 stem cell marker,” British Journal of Dermatology, vol. 156, no. 2, pp. 378–380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Fusi, S. Ochsenreither, A. Busse, A. Rietz, and U. Keilholz, “Expression of the stem cell marker nestin in peripheral blood of patients with melanoma,” British Journal of Dermatology, vol. 163, no. 1, pp. 107–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Okudela, T. Woo, H. Mitsui, M. Tajiri, M. Masuda, and K. Ohashi, “Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma—their prognostic significance,” Pathology International, vol. 62, no. 12, pp. 792–801, 2012. View at Publisher · View at Google Scholar
  21. F. Zeppernick, R. Ahmadi, B. Campos et al., “Stem cell marker CD133 affects clinical outcome in glioma patients,” Clinical Cancer Research, vol. 14, no. 1, pp. 123–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Maw, D. Corbeil, J. Koch et al., “A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration,” Human Molecular Genetics, vol. 9, no. 1, pp. 27–34, 2000. View at Scopus
  23. C. V. Pfenninger, T. Roschupkina, F. Hertwig et al., “CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells,” Cancer Research, vol. 67, no. 12, pp. 5727–5736, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Corbeil, K. Röper, A. Hellwig et al., “The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions,” Journal of Biological Chemistry, vol. 275, no. 8, pp. 5512–5520, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Wang, P. Ø. Sakariassen, O. Tsinkalovsky et al., “CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells,” International Journal of Cancer, vol. 122, no. 4, pp. 761–768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Ferrandina, E. Martinelli, M. Petrillo et al., “CD133 antigen expression in ovarian cancer,” BMC Cancer, vol. 9, article 221, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Kemper, M. R. Sprick, M. de Bree et al., “The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation,” Cancer Research, vol. 70, no. 2, pp. 719–729, 2010. View at Publisher · View at Google Scholar · View at Scopus